Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

15.15
BATS BZX Real-Time Price
As of 3:19pm ET
 -0.90 / -5.61%
Today’s Change
7.86
Today|||52-Week Range
19.90
+0.66%
Year-to-Date
Analysts' Actions -- Discovery, First Solar, Momenta, VF Corp. and More
8:13am / TheStreet.com - Paid Partner Content
Drug Stocks Q4 Earnings Lineup for Feb 21: IRWD, MNTA, EXAS
Feb 20 / Zacks.com - Paid Partner Content
Why Momenta Pharmaceuticals, Northern Dynasty Minerals, and Unilever Slumped Today
Feb 21 / MotleyFool.com - Paid Partner Content
Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks
Feb 16 / MotleyFool.com - Paid Partner Content
Why Momenta Pharmaceuticals, Inc. Shares Got Crushed Today
Feb 21 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: MidWestOne Financial Group, Brooks Automation, Cro...
Feb 14 / Zacks.com - Paid Partner Content
Why Momenta Pharmaceuticals, Inc. Shares Got Crushed Today
Feb 21 / MotleyFool.com - Paid Partner Content
Forget Gilead, Buy These 5 Biotech Stocks Instead
Feb 13 / Zacks.com - Paid Partner Content
Sarepta Leads Biotech Movers on Voucher Deal News
Feb 21 / TheStreet.com - Paid Partner Content
5 Stocks to Buy as Trump Chalks Out 'Phenomenal' Tax Plan
Feb 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close16.05
Today’s open15.60
Day’s range15.15 - 15.70
Volume54,656
Average volume (3 months)651,212
Market cap$1.1B
Dividend yield--
Data as of 3:19pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)+30.89%
Earnings growth (this year)+12.64%
Earnings growth (next 5 years)--
Revenue growth (last year)+71.58%
P/E ratioNM
Price/Sales10.45
Price/Book2.99

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...-0.51-1.51%
CHRSCoherus BioSciences ...-1.00-4.41%
EDITEditas Medicine Inc-3.66-13.42%
XLRNAcceleron Pharma Inc-0.92-3.48%
Data as of 3:20pm ET, 02/22/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$89.7M
Annual profit (last year)-$83.3M
Net profit margin-92.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Operating Officer
Matthew P. Ottmer
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs